Original Paper |
|
|||
|
Acta Biochim Biophys |
||||
|
doi:10.1111/j.1745-7270.2006.00201.x |
Integrin b1A Upregulates
p27 Protein Amount at the Post-translational Level in Human Hepatocellular
Carcinoma Cell Line SMMC-7721
Yi FU1,3,
Li-Ying WANG1, Yu-Long LIANG1,
Jia-Wei JIN1, Zheng-Yu FANG1,
and Xi-Liang ZHA1,2*
1 Department of Biochemistry and Molecular Biology,
and
2 Key Laboratory of Molecular Medicine,
Ministry of Education, Shanghai Medical College, Fudan University, Shanghai
200032, China;
3 Department of Biochemistry, Medical
College, Yangzhou University, Yangzhou 225001, China
Received: April 19,
2006
Accepted: May 21,
2006
This work was
supported by a grant from the National Natural Science Foundation of China
(No. 30570963)
*Corresponding
author: Tel, 86-21-54237696; Fax, 86-21-64179832; E-mail, [email protected]
Abstract Integrins mediate many fundamental cellular processes by
binding to components of the extracellular matrix. We showed previously that
integrin b1A could
inhibit cell proliferation. Integrin b1A
stimulated the promoter activity of p21cip1 and enhanced its transcription in SMMC-7721 cells. In this
study, we demonstrated that integrin b1A
upregulated p27kip1 at the post-translational
level in SMMC-7721 cells. Our results showed that integrin b1A increased the p27 protein
amount, both in cytoplasm and nucleus, but did not affect the p27 mRNA amount.
Cycloheximide treatment experiment revealed that the half-life of p27 protein
was prolonged in integrin b1A
overexpressing cells, indicating that integrin b1A inhibited the degradation of p27 protein.
Our data also provided evidence that both the proteasome and calpain were
involved in the degradation of p27 protein in SMMC-7721 cells. Integrin b1A decreased the Skp2 expression
and repressed the activity of calpain during G1 phase in SMMC-7721 cells. Taken
together, these results indicated that integrin b1A might upregulate the protein amount of
p27 through repressing Skp2-dependent proteasome degradation and
calpain-mediated proteolysis in SMMC-7721 cells.
Key words integrin; p27kip1; degradation; calpain; Skp2
As heterodimeric transmembrane receptors, integrins recognize and
bind extracellular matrix (ECM) ligands, participating in the regulation of
cell differentiation, growth control, cellular migration and invasion.
Integrins initiate and modulate a number of transduction cascades, such as
activation of extracellular signal-regulated protein kinase, the c-Jun NH2-terminal kinase, and activation of phosphatidylinositol-3‘
kinase/protein kinase B [1,2]. Integrins, often together with growth factor
receptors, upregulate cyclins D and E, or downregulate cyclin-dependent kinase
inhibitors p21cip1, p27kip1 and p57kip2, and this can result in cell cycle progression [3,4]. However, many
studies have demonstrated that integrins give rise to growth inhibition rather
than growth stimulation [5–7]. For example, the specific isoform of integrin b1 subunits, b1C, has been shown to inhibit
cell proliferation in prostatic adenocarcinoma [7]. It is apparent from these studies that integrin signaling might play
a major role in negative control of cell growth, which might be lost in some
cancer cells. Integrin a5b1 has been observed to be lost in cancerous areas other than in its
normal counterpart tissues [8].
In human hepatocellular carcinoma (HCC), the expression of integrin a5b1 is much lower
than in normal hepatocytes [9], implying that the downregulation of integrins
might promote proliferation of carcinoma cells, and overexpression of integrins
might inhibit cell growth of cancers. Based on this hypothesis, a full-length b1A
integrin isoform was stably transfected into SMMC-7721 cells [10] in order to
inhibit cell growth. As expected, integrin b1A inhibited cell proliferation,
and induced S-phase arrest. Then we found that integrin b1A
stimulates the promoter activity of p21cip1 and enhances its transcription in SMMC-7721 cells [10]. To further
investigate the mechanism of cell growth inhibition, we observed the
relationship between integrin b1A and the other cip/kip family member, p27kip1 (here referred to as p27).
As an important cyclin-dependent kinase inhibitor, p27 binds to
cyclin/cyclin-dependent kinase complex, and subsequently plays important roles
in cell cycle arrest, cell apoptosis and differentiation. Accumulating evidence
indicates that the expression of p27 is mainly regulated post-translationally
in many cancer cells, especially at the protein degradation level [11].
In this study, we found that integrin b1A increased the p27 protein
amount, both in cytoplasm and nucleus, but did not affect the p27 mRNA amount
in SMMC-7721 cells. The upregulation of the amount of p27 protein was mediated
by two different degradation mechanisms, proteasome and calpain.
Materials and Methods
Cell culture and reagents
The HCC cell line SMMC-7721 was obtained from the Liver Cancer
Institute, Zhongshan Hospital, Fudan University (Shanghai, China). The
mock-7721 and integrin b1A overexpressing 7721 (b1-7721) cell lines were constructed as described
previously [10]. Cells were cultured in RPMI 1640 (Gibco BRL, Carlsbad, USA)
supplemented with 10% calf bovine serum and 500 mg/ml geneticin (G418; Gibco
BRL), and incubated at 37 ºC in an incubator with 95% air and 5% CO2.
Antibodies against human p27 (F-8), p45Skp2
(H-435), poly(ADP-ribose) polymerase (F-2), a-tubulin (B-7), and
glyceraldehyde-3-phosphate dehydrogenase were purchased from Santa Cruz
Biotechnology (Santa Cruz, USA), and monoclonal antibody against integrin b1 subunit
was from BD Transduction Laboratories (San Jose, USA). MG132, chloroquine,
MDL28170, and aphidicolin were from Calbiochem (San Diego, USA).
Semi-quantitative reverse
transcription-polymerase chain reaction (RT-PCR)
The total RNAs were isolated using the Trizol system (Watson
Biotechnologies, Shanghai, China) according to the manufacturer’s guidelines.
Semi-quantitative RT-PCR was carried out to quantify the mRNA amounts of
p27 and Skp2 genes. (dT)15-primer and avian myeloblastosis
virus RTase were used for the first strand synthesis. Two microliters of cDNA
product was mixed with Taq DNA polymerase (SABC, Luoyang, China), 50 pM
of each appropriate primer, 200 mM of each dNTP in a reaction buffer containing
10 mM Tris-HCl (pH 8.3), 50 mM KCl, 0.01% (W/V) bovine serum
albumin, and 2 mM MgCl2 in a final volume of 100 ml. A
housekeeping gene, b-actin, was used as the internal
control. The primers for p27 and b-actin were as follows: 5‘-AAGTGGCATGTTTTGTGCATTT-3‘ (F)
and 5‘-GCTCAGTATGCAACCTTTTAAGCA-3‘ (R) for p27; and 5‘-TGGGCATGGGTCAGAAGGAT-3‘
(F) and 5‘-AAGCATTTGCGGTGGACGAT-3‘ (R) for b-actin. The primers for Skp2 were described previously [12]. The
expected product sizes of p27, Skp2 and b-actin were 100 bp, 271 bp and 991 bp, respectively. The samples were
amplified for 25 cycles at a cyclic temperature of 94 ºC for 30 s, 55 ºC for
30 s (for p27 and b-actin), or 57 ºC for 30 s (for Skp2),
and 72 ºC for 60 s. PCR products were analyzed using 1% agarose gel electrophoresis
following ethidium bromide staining. The band densitometry scanning of p27
or Skp2 was measured and normalized by that of b-actin.
Cell lysis and immunoblotting
Cultured cells were harvested with trypsinization and
centrifugation, then rinsed twice in ice-cold phosphate-buffered saline (PBS),
and lysed in 1´sodium dodecylsulfate (SDS) lysis
buffer [50 mM Tris-HCl, pH 6.8, 2% SDS, 10% glycerol, 100 mg/ml
phenylmethylsulphonyl fluoride (PMSF), 10 mg/ml leupeptin and 5 mM Na3VO4] for 30 min on ice. The protein samples were
boiled and centrifuged at 12,000 g for 10 min at 4 ºC. The supernatants
were transferred to a microcentrifuge tube and stored at –20 ºC. Protein
lysates were resolved by SDS-polyacrylamide gel electrophoresis and transferred
onto polyvinylidene difluoride membranes. The membranes were blocked in PBST
(PBS containing 0.05% Tween-20) containing 5% non-fat dry milk and incubated
with appropriate primary antibodies diluted in PBST containing 5% milk
overnight at room temperature. Following three washes in PBST, the blots were
incubated with the horseradish peroxidase-conjugated secondary antibody.
Finally, these blots were washed three times in PBST, and developed by enhanced
chemiluminescence (Boxin, Shanghai, China).
Subcellular fractionation
Subcellular fractionation was carried out as described previously
[13]. Briefly, cells were lysed in an ice-cold solution containing 0.02% digitonin,
5 mM sodium phosphate (pH 7.4), 50 mM NaCl, 150 mM sucrose, 5 mM KCl, 2 mM dithiothreitol
(DTT), 1 mM MgCl2, 0.5 mM CaCl2, and
0.1 mM PMSF. The cytoplasmic fraction was collected after centrifugation of
lysates at 1000 g for 10 min at 4 ºC. The resulting pellet was
resuspended in the lysis solution without digitonin and loaded onto a cushion
of a solution containing 30% (W/V) sucrose, 2.5 mM Tris-HCl (pH
7.4), and 10 mM NaCl. After centrifugation at 1000 g for 10 min at 4 ºC,
nuclei were collected and extracted for 30 min at 4 ºC with an ice-cold
solution containing 0.5% (V/V) Triton X-100, 50 mM Tris-HCl (pH
7.5), and 300 mM NaCl. After centrifugation of the extract at 12,000 g for
10 min at 4 ºC, the supernatant was collected as the nuclear fraction.
Cell synchronization and cell
cycle analysis
The mock-7721 cells were starved by exposure to serum-free medium
for 48 h for synchronization at the G1 phase. To synchronize cells at the S
phase, mock-7721 cells were cultured in the presence of 15 mM aphidicolin
for 30 h and harvested. The harvested cells were digested with 2 mM EDTA in PBS
and rinsed twice with ice-cold PBS solution, then fixed by adding them dropwise
into 75% ice-cold ethanol while vortexing, followed by incubation on ice for
60 min. The fixed cells were washed with ice-cold PBS and incubated at 37 ºC
for 30 min in 0.5 ml PBS solution containing 20 mg/ml RNase A, 0.2% Triton
X-100, 0.2 mM EDTA and 20 mg/ml of propidium iodide. DNA content was determined
by fluorescence-activated cell sorting analysis (Becton Dickinson, San Jose,
USA). The percentage of cells in G1, S, and G2/M phases was determined using
the ModFit program (Cell Quest software; Becton Dickinson).
Calpain zymograms
Calpain activity assay was carried out using the method of Delmas et
al. [14] with modifications. For zymographic detection of calpain, cells
were harvested in lysis buffer (20 mM Tris, pH 7.4, 150 mM NaCl, 5 mM EDTA, 5
mM EGTA, 1% Triton X-100, 1 mM DTT, 1 mM pepstatin, 1 mM aprotinin, and 100 mM PMSF). Equal
samples were treated with loading buffer (150 mM Tris-HCl, pH 6.8, 2 mM
2-mercaptoethanol, 20% glycerol, and 0.02% bromphenol blue), then separated in
nondenaturing conditions (10% polyacrylamide gel containing 0.2% casein). The
casein gel was prerun with a buffer containing 25 mM Tris-base, 192 mM glycine,
1 mM EDTA and 1 mM DTT (pH 8.3) for 30 min at 4 ºC (125 V), then as needed at
125 V for approximately 3 h in an ice-water bath. After the migration, the gel
was incubated in 20 mM Tris-HCl (pH 7.4), 10 mM DTT and 5 mM CaCl2 with slow shaking for 60 min (with two changes of buffer) at room
temperature. As a control, a second gel was incubated in the same buffer with 5
mM EGTA instead of calcium. The gels were then further incubated overnight (20–24 h) at ambient
temperature in the same buffer. Finally, gels were fixed using 10% acetic
acid-25% methanol and stained with Coomassie blue.
Results
Integrin b1A upregulated p27 protein
amount, but not mRNA amount
To investigate the mechanism of integrin b1A inhibition of cell growth in
SMMC-7721, we determined the protein and mRNA amount of p27 in mock-7721 and b1-7721 cells. As
shown in Fig. 1(A), after stable transfection of integrin b1A
subunit, the amount of integrin b1A protein increased approximately 2.5-fold compared with mock-7721
cells. The b1A subunit appeared as two bands in Western blot because of variable
post-translational modification (mainly N-glycosylation). The lower band was
tentatively identified as the biosynthetic precursor of b1A
subunit, which is hypoglycosylated [15]. The upper band was in
hyperglycosylated form, and mainly located in the plasmic membrane.
Correspondingly, the protein amount of p27 was also more than 2.5-fold higher
in b1-7721
cells compared with mock-7721 cells. However, RT-PCR results showed that the
mRNA amounts of p27 in these two cells was not significantly different [Fig.
1(B)]. Furthermore, we analyzed the subcellular distribution of p27 protein
in b1-7721
cells. According to the method described in “Materials and Methods”,
we separated the cellular cytoplasm from the nucleus of mock-7721 and 1-7721
cells, using a-tubulin and poly(ADP-ribose) polymerase (PARP) as cytoplasmic and
nuclear controls, respectively. As shown in Fig. 1(C), the protein
amounts of p27 in both cytoplasm and nucleus were increased in b1-7721 cells,
compared with mock-7721 cells. These results implied that upregulation of the
amount of p27 protein might be involved in the growth inhibition in integrin b1A
overexpressing cells.
Integrin b1A prolonged the half-life of
p27 protein
To explore the mechanism of the upregulation of p27 protein amount
by integrin b1A, we detected the stability of p27 in b1-7721 cells compared with
mock-7721 cells. Cells were treated with 50 mg/ml cycloheximide (which inhibits
the translation of mRNA) at 0, 2, 4, and 8 h, then the decay of p27 was
observed. Cell lysates were prepared and equal amounts of protein were loaded
on SDS-polyacrylamide gel electrophoresis and blotted with an anti-p27
antibody. As shown in Fig. 2(A), the p27 protein disappeared faster in
mock-7721 cells than in b1-7721 cells. The results showed that the half-life of p27 was less
than 2 h in mock-7721 cells, but longer than 6 h in b1-7721 cells [Fig. 2(B)].
These data indicated that integrin b1A could upregulate the amount of p27 protein at the
post-translational level by increasing the stability of p27 protein.
Degradation of p27 protein was
both proteasome- and calpain-dependent in SMMC-7721 cells
It has been reported that several mechanisms are involved in p27
protein degradation, including proteasome-dependent and -independent pathways
[14,16–18]. In order to obtain some insights into the post-translational
mechanism of the upregulation of the amount of p27 protein by integrin b1A, the
occurrence of the proteasome- and calpain-mediated proteolysis in the
degradative processes of p27 protein was investigated. The mock-7721 and b1-7721 cells
were incubated with either proteasome inhibitor MG132 (10 mM), or calpain
inhibitor MDL28170 (10 mM) for 6 h, then the changes in p27 protein amounts were observed.
As shown in Fig. 3(A), the p27 protein amount was increased in mock-7721
cells but remained stable in b1-7721 cells in the presence of MG132. Similar results were obtained
when MDL28170 was used [Fig. 3(B)]. Because it has been known that MG132
inhibits not only the proteasome but also cathepsins in the lysosome [19], we
used the lysosome inhibitor chloroquine (20 mM) as a control. Fig.
3(C) shows that the protein amounts of p27 did not change in the presence
of chloroquine, neither in mock-7721 nor in b1-7721 cells. These results
indicated that both proteasome- and calpain-mediated proteolysis pathways were
involved in the degradation of p27 protein in SMMC-7721 cells. It also implied
that overexpression of integrin b1A suppressed the proteasome- and calpain-mediated p27 degradation;
MG132 and MDL28170 might no longer play inhibitory roles in b1-7721 cells.
Integrin b1A inhibited the expression of
Skp2 and activity of calpain
Increasing evidence indicates that Skp2 (S-phase kinase-associated
proteins), an F-box protein of SCF E3 ligase, specifically recognizes and binds
to p27, then promotes the ubiquitination and proteasome-mediated degradation of
p27. Skp2 is restricted to the nucleus, therefore it mediates the
proteasome-dependent degradation of p27 in nucleus [20]. Because integrin b1A
induced the accumulation of p27 protein in nucleus, the role of Skp2 was
investigated. As shown in Fig. 4(A), compared with mock-7721 cells,
reduced amounts of Skp2 mRNA and protein were observed in b1-7721 cells,
indicating that downregulation of Skp2 expression induced by integrin b1A might
result in the upregulation of p27 protein in nucleus.
We then investigated whether integrin b1A was involved in calpain
activity regulation. We undertook zymographic detection of calpain proteolytic
activity from cell extracts of mock-7721 and b1-7721 cells. The calpains
are a family of non-lysosomal, calcium-dependent cytosolic cysteine proteases.
The calpains consist of an 80 kDa large subunit, m– or m-calpains, each of
which forms a heterodimer with a common 28 kDa small subunit [14]. As shown in Fig.
4(B), when the gel was incubated with calcium, the
activities of m– and m-calpain could be detected. When the gel was incubated with EGTA
instead of calcium, as a control, the proteolytic
activities were not observed. Moreover, both the m– and m-calpain
activities in b1-7721 cells were reduced compared with mock-7721 cells. These results
indicated that the upregulation of p27 protein in cytoplasm might result from
the inhibition of the activity of calpain by integrin b1A.
Proteasome- and
calpain-mediated protein degradation of p27 occurred during G1 phase
Previous reports have revealed that the amount of p27 protein
fluctuates over the course of the cell cycle [11]. To determine whether
proteasome- and calpain-mediated p27 protein degradation pathways are cell
cycle-dependent, cells were treated with proteasome inhibitor or calpain
inhibitor at different cell cycle phases. Fig. 5(A) shows the results of
cell cycle analysis using flow cytometry. After serum-free medium or
aphidicolin treatment, mock-7721 cells were arrested at G1 or S phase. Because
mock-7721 cells were more sensitive to proteasome and calpain inhibitors than b1-7721 cells,
mock-7721 cells synchronized at G1 or S phase were treated with either MG132
(10 mM) or MDL28170 (10 mM) for 6 h. We found that treatment with MG132 only increased the
p27 protein amount in G1-arrest cells, but had no effects on cells arrested at
S phase. Similar results were obtained from treatment with MDL28170 [Fig.
5(B)]. These results indicated that both the proteasome- and
calpain-mediated protein degradation of p27 in SMMC-7721 occurred during G1
phase.
Discussion
A number of recent studies have demonstrated the prognostic
significance of p27 protein in many human cancers. Decreased protein amount of p27
is associated with aggressive, high grade human breast, colorectal and gastric
cancer with poor clinical outcome [11]. Because of the prognostic value, the
expression regulation of p27, particularly the protein degradation of p27, has
emerged as a critical area of research in growth control in a wide variety of
tumors.
Integrins are a large family of a/ heterodimeric
transmembrane receptors binding to components of the ECM. By outside-in and
inside-out signaling events, integrins mediate many fundamental cellular
processes, such as proliferation, spreading, migration and differentiation
[1,2]. In general, integrins modulate cellular functions by regulating the
transcription of genes through signaling pathways. Here, we reported that
integrins could play roles through affecting the degradation of protein.
Previous studies have reported that forced expression of integrin b1C inhibits cell growth and
increases p27 protein amount in prostatic adenocarcinoma [7,21]. However, the detailed mechanism involved in this correlation was not
investigated. In our previous study, it was demonstrated that integrin b1A
inhibits cell proliferation in SMMC-7721 [10]. In the present study, we found
that integrin b1A upregulated the p27 protein amount, both in cytoplasm and nucleus,
but did not affect the p27 mRNA amount in SMMC-7721. Cycloheximide treatment
experiment showed that integrin b1A prolonged the half-life of p27 protein and increased the p27
protein stability. It is implied that integrin b1A upregulated the amount of p27
protein by suppressing the degradation of p27 protein, which might be involved
in the cell growth inhibition in SMMC-7721.
Proteasome and calpain are different protease complexes that mediate
the proteolysis of many proteins. The proteasome mainly plays an important role
in the degradation of short half-life proteins, including those that
participate in the cell cycle, cellular signaling in response to stress and to
extracellular signals, morphogenesis, the secretory pathway, DNA repair, and
organelle biogenesis [22]. The calpains are intracellular cysteine proteases
that require Ca2+ ions for activity. Proteolysis through the
calcium-dependent calpain is thought to be involved in housekeeping functions,
including cytoskeletal protein interactions, receptor processing and regulation
of numerous transducing enzymes, and in numerous pathologies that include
muscular dystrophy, cancer, cataracts, diabetes and Alzheimer’s disease [23].
In this study, we treated the mock-7721 and b1-7721 cells with proteasome
and calpain inhibitors. The results showed that both proteasome and calpain
mediated the degradation of p27 protein, and implied that integrin b1A might
suppress the proteasome- and calpain-mediated p27 degradation in SMMC-7721
cells.
Skp2-dependent proteasome degradation of p27 protein has been well
characterized. Skp2 can specifically recognize Thr187-phosphorylated p27, then
promote the degradation of p27 protein in nucleus [20,24]. In many cancers, the
reduced expression of p27 is usually associated with increased expression of
Skp2 [25]. Zhang et al. [26] reported that integrin b1 can
modulate the responsiveness of hepatoma cells to hepatocyte growth factor in a
p27-dependent manner by increasing Skp2, which prompted us to examine the role
of Skp2 in b1-7721 cells. The results revealed that integrin b1A
inhibited the expression of Skp2 at both mRNA and protein levels, suggesting,
at least partially, that increased p27 protein amount in nucleus might result
from the expression suppression of Skp2 by integrin b1A. Carrano et al. [27]
reported that cell adhesion can regulate the expression of Skp2. Bond et al.
[28] also found that the vascular ECM regulates the protein stability of Skp2
and hence the degradation of p27 by focal adhesion kinase (FAK) signaling.
Phosphatase and Tensin homolog deleted on chromosome Ten (PTEN) or
phosphatidylinositol-3‘ kinase
inhibitor LY294002 can upregulate the protein amount of p27 by decreasing the
expression of Skp2 [29,30]. Integrins are important molecules mediating cell
adhesion. Therefore, whether integrin b1A downregulated the expression of Skp2 by adhesion, and which
signaling pathway might be involved in this regulation, need further
investigation.
We found that both Skp2-dependent proteasome degradation and calpain-mediated
proteolysis were repressed by integrin b1A in SMMC-7721 cells. The
Skp2-dependent degradation degrades p27 protein in nucleus, whereas calpain
plays its roles mainly in cytoplasm, which suggested that these two degradation
pathways are spatially separate. However, it remains obscure which degradation
pathway takes function firstly, and which afterwards. Our results showed that
both proteasome and calpain exerted their proteolysis roles on p27 protein
during G1 phase. It has been reported that p27 is exported from the nucleus to
the cytoplasm at G0-early G1 phase [13]. Moreover, Skp2-dependent proteasome
degradation of p27 protein occurs during late G1-S phase [20,24]. These
observations suggested that calpain-mediated p27 protein degradation might precede
proteasome in SMMC-7721 cells, although both of them occurred during G1 phase.
Furthermore, the activity of calpain was inhibited by integrin b1A.
Interestingly, it has been reported that many integrin subunits (including b1A, b1D, b2, b3, b4 and b7) are
calpain-sensitive [31]. Calpain cleaves b-integrin tails at sites
between and adjacent to the conserved NPXY/NXXY motifs. For example, calpain
cleaves the integrin b3 cytoplasmic domain at the membrane-distal regions near the two NXXY
motifs. These motifs mediate signal transduction, focal adhesion formation, and
integrin-cytoskeletal interactions, thereby regulating the affinity state of
the receptor [32]. It implied that integrin b1 might be a target of calpain. But
in this study, we showed that integrin b1A inhibited the activity of
calpain. The mechanism of integrin b1A repression in calpain activity warrants further investigation.
We have demonstrated that integrin b1A could inhibit cell
proliferation in HCC cell line SMMC-7721 [10]. In this study, we found that
integrin b1A could increase the protein amount of p27 by inhibiting the
degradation of p27 protein in SMMC-7721. Of course, to further confirm this
inhibition, the role of integrin b1A on p27 protein degradation, silencing the expression of integrin b1A will
be done. Because of the important clinical significance of p27 protein in
tumors, we hope that the increased expression of p27 induced by integrin b1A could
provide a new strategy on tumor treatment.
References
1 Giancotti FG. A structural view of integrin
activation and signaling. Dev Cell 2003, 4: 149–151
2 Harris ES, McIntyre TM, Prescott SM,
Zimmerman GA. The leukocyte integrins. J Biol Chem 2000, 275: 23409–23412
3 Schwartz MA. Integrin signaling revisited.
Trends Cell Biol 2001, 11: 466–470
4 Sherr CJ, Roberts JM. CDK inhibitors:
Positive and negative regulators of G1-phase progression. Genes Dev 1999, 13: 1501–1512
5 Varner, JA, Emerson DA, Juliano RL. Integrin a5b1 expression
negatively regulates cell growth: Reversal by attachment to fibronectin. Mol
Biol Cell 1995, 6: 725–740
6 Henriet P, Zhong ZD, Brooks PC, Weinberg KI,
DeClerck YA. Contact with fibrillar collagen inhibits melanoma cell
proliferation by up-regulating p27KIP1. Proc Natl Acad
Sci USA 2000, 97: 10026–10031
7 Fornaro M, Manzotti M, Tallini G, Slear AE,
Bosari S, Ruoslahti E, Languino LR. b1C integrin in
epithelial cells correlates with a nonproliferative phenotype: Forced
expression of b1C inhibits prostate
epithelial cell proliferation. Am J Pathol 1998, 153: 1079–1087
8 Su JM, Gui L, Zhou YP, Zha XL. Expression of
focal adhesion kinase and a5 and b1 integrins in
carcinomas and its clinical significance. World J Gastroenterol 2002, 8: 613–618
9 Yao M, Zhou XD, Zha XL, Shi DR, Fu J, He JY,
Lu HF et al. Expression of the integrin a5 subunit and its
mediated cell adhesion in hepatocellular carcinoma. J Cancer Res Clin Oncol
1997, 123: 435–440
10 Liang YL, Fu Y, Chen SG, Cai XM, Su JM, Jin
JW, Ma DZ et al. Integrin b1 subunit overexpressed in the
SMMC-7721 cells regulates the promoter activity of p21CIP1 and enhances its
transcription. FEBS Lett 2004, 558: 107–113
11 Slingerland J, Pagano M. Regulation of the cdk
inhibitor p27 and its deregulation in cancer. J Cell Physiol 2000, 183: 10–17
12 Radke S, Pirkmaier A, Germain D. Differential
expression of the F-box proteins Skp2 and Skp2B in breast cancer. Oncogene
2005, 24: 3448–3458
13 Ishida N, Hara T, Kamura T, Yoshida M,
Nakayama K, Nakayama KI. Phosphorylation of p27Kip1 on serine 10 is
required for its binding to CRM1 and nuclear export. J Biol Chem 2002, 277:
14355–14358
14 Delmas C, Aragou N, Poussard S, Cottin P,
Darbon JM, Manenti S. MAP kinase-dependent degradation of p27Kip1 by calpains in
choroidal melanoma cells. Requirement of p27Kip1 nuclear export. J
Biol Chem 2003, 278: 12443–12451
15 Heino J, Ignotz RA, Hemler ME, Crouse C,
Massague J. Regulation of cell adhesion receptors by transforming growth factor-b. Concomitant
regulation of integrins that share a common b1 subunit. J Biol
Chem 1989, 264: 380–388
16 Montagnoli A, Fiore F, Eytan E, Carrano AC,
Draetta GF, Hershko A, Pagano M. Ubiquitination of p27 is regulated by
Cdk-dependent phosphorylation and trimeric complex formation. Genes Dev 1999,
13: 1181–1189
17 Shirane M, Harumiya Y, Ishida N, Hirai A,
Miyamoto C, Hatakeyama S, Nakayama K et al. Down-regulation of p27Kip1 by two mechanisms,
ubiquitin-mediated degradation and proteolytic processing. J Biol Chem 1999,
274: 13886–13893
18 Patel YM, Lane MD. Mitotic clonal expansion
during preadipocyte differentiation: Calpain-mediated turnover of p27. J Biol
Chem 2000, 275: 17653–17660
19 Marques C, Pereira P, Taylor A, Liang JN,
Reddy VN, Szweda LI, Shang F. Ubiquitin-dependent lysosomal degradation of the
HNE-modified proteins in lens epithelial cells. FASEB J 2004, 18: 1424–1426
20 Carrano AC, Eytan E, Hershko A, Pagano M. SKP2
is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell
Biol 1999, 1: 193–199
21 Fornaro M, Tallini G, Zheng DQ, Flanagan WM,
Manzotti M, Languino LR. p27kip1 acts as a
downstream effector of and is coexpressed with the b1C integrin in
prostatic adenocarcinoma. J Clin Invest 1999, 103: 321–329
22 Hatakeyama S, Yada M, Matsumoto M, Ishida N,
Nakayama KI. U box proteins as a new family of ubiquitin-protein ligases. J
Biol Chem 2001, 276: 33111–33120
23 Dulong S, Goudenege S, Vuillier-Devillers K,
Manenti S, Poussard S, Cottin P. Myristoylated alanine-rich C kinase substrate
(MARCKS) is involved in myoblast fusion through its regulation by protein
kinase Ca and calpain proteolytic cleavage. Biochem J 2004,
382: 1015–1023
24 Sutterluty H, Chatelain E, Marti A, Wirbelauer
C, Senften M, Muller U, Krek W. p45SKP2 promotes p27Kip1 degradation and
induces S phase in quiescent cells. Nat Cell Biol 1999, 1: 207–214
25 Gstaiger M, Jordan R, Lim M, Catzavelos C,
Mestan J, Slingerland J, Krek W. Skp2 is oncogenic and overexpressed in human
cancers. Proc Natl Acad Sci USA 2001, 98:5043–5048
26 Zhang H, Ozaki I, Mizuta T, Yoshimura T,
Matsuhashi S, Hisatomi A, Tadano J et al. Mechanism of b1-integrin-mediated
hepatoma cell growth involves p27 and S-phase kinase-associated protein 2.
Hepatology 2003, 38: 305–313
27 Carrano AC, Pagano M. Role of the F-box
protein Skp2 in adhesion-dependent cell cycle progression. J Cell Biol 2001,
153: 1381–1390
28 Bond M, Sala-Newby GB, Newby AC. Focal
adhesion kinase (FAK)-dependent regulation of S-phase kinase-associated
protein-2 (Skp-2) stability. A novel mechanism regulating smooth muscle cell
proliferation. J Biol Chem 2004, 279: 37304–37310
29 Pene F, Claessens YE, Muller O, Viguie F,
Mayeux P, Dreyfus F, Lacombe C et al. Role of the phosphatidylinositol
3-kinase/Akt and mTOR/P70S6-kinase pathways in the proliferation and apoptosis
in multiple myeloma. Oncogene 2002, 21: 6587–6597
30 Mamillapalli R, Gavrilova N, Mihaylova VT,
Tsvetkov LM, Wu H, Zhang H, Sun H. PTEN regulates the ubiquitin-dependent
degradation of the CDK inhibitor p27KIP1 through the
ubiquitin E3 ligase SCFSKP2. Curr Biol 2001, 11: 263–267
31 Moro L, Perlino E, Marra E, Languino LR, Greco
M. Regulation of b1C and b1A integrin
expression in prostate carcinoma cells. J Biol Chem 2004, 279: 1692–1702
32 Zhao R, Pathak AS, Stouffer GA. b3-Integrin
cytoplasmic binding proteins. Arch Immunol Ther Exp 2004, 52: 348–355